Over 7000 potentially life-threatening rare diseases exist, with no available treatment options.
We aspire to leverage our existing rare disease development and commercial capabilities to partner with other companies whose mission and core values align with Pharming’s commitment to serve patients.
Pharming seeks to augment its current development pipeline with mid-to late-stage clinical assets in the rare disease space spanning a variety of therapeutic areas and indications.
Contact our BD team
Our Business Development team regularly attends major industry conferences and partnering meetings. Please contact us at bd@pharming.com with an opportunity that you would like to discuss.